The Treatment of Polycystic Ovary Syndrome
February 2004
in “
PubMed
”
polycystic ovary syndrome PCOS androgen levels clomiphene citrate gonadotrophin therapy laparoscopic ovarian diathermy recombinant FSH GnRH-agonists metformin cabergoline hirsutism hyperandrogenemia oral contraceptives insulin-sensitizing agents insulin resistance Clomid FSH GnRH birth control pills
TLDR PCOS treatment focuses on inducing ovulation, reducing androgens, and managing long-term health risks with medications and lifestyle changes.
The treatment of polycystic ovary syndrome (PCOS) in 2004 focused on symptom-oriented approaches due to the unclear etiology of the condition. The primary goals were to induce ovulation for conception, reduce androgen levels, manage body weight, and mitigate long-term health risks like diabetes and cardiovascular disease. Clomiphene citrate (CC) was the first-line treatment for ovulation induction, with alternatives for CC-resistant patients including gonadotrophin therapy and laparoscopic ovarian diathermy. Recombinant FSH (rFSH) showed promise for being more effective than urinary FSH. The addition of GnRH-agonist could enhance treatment outcomes. Metformin and cabergoline were also under investigation. For hirsutism, treatments aimed at androgen suppression included oral contraceptives, GnRH analogues, and insulin-sensitizing agents. Weight reduction and exercise were recommended to improve menstrual disturbances, infertility, and insulin resistance.